Biopsy Devices: Technologies and Global Markets

Report Highlights

The global biopsy devices market should reach $3.1 billion by 2027 from $2.2 billion in 2022 at a compound annual growth rate (CAGR) of 6.8% for the forecast period of 2022 to 2027.

Report Includes

• 44 data tables and 21 additional tables
• Detailed overview and an up-to-date analysis of the global market for biopsy devices
• Analyses of the global market trends, with revenue data (sales figures) for 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027
• Estimation of the actual market size and revenue forecast for the global biopsy devices market, and corresponding market share analysis by device type, therapeutic area/application, image guiding technology, end user, and region
• Identification of the viable technology drivers and barriers through a holistic review of various next generation imaging technologies used in the process of performing biopsies and their key therapeutic areas in the cancer diagnostics market
• Review of cancer statistics and epidemiology insights and SWOT analysis of various cancer biotherapeutics present in the market
• A look at major issues and trends with relate to the R&D of more effective cancer treatment, and new cancer therapeutics in development, and outlook on cancer clinical trials
• Assessment of the market growth opportunities, SWOT analysis of the leading companies engaged in manufacturing and development of biopsy devices, emerging trends and technology developments, along with the COVID-19 implications on the marketplace
• Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
• Patent grants and patent applications on biopsy devices and cancer diagnostics industry
• Descriptive company profiles of the leading market players, including Argon Medical Devices Inc., Boston Scientific Corp., FujiFilm Holdings Corp., Mammotome, and Olympus Corp.

Report Scope

This research report presents an in-depth analysis of the global market for biopsy devices, segmented by product type, imaging technique, application, end user and geographic markets. It discusses key devices (vacuum-assisted biopsy [VAB] devices, fine needle aspiration biopsy [FNAB] devices, core needle biopsy [CNB] devices, biopsy guidance systems, biopsy needles, biopsy forceps and others). Applications include trends and market estimates of key application areas (breast cancer, gastrointestinal cancer, lung cancer, liver cancer, prostate cancer and cervical cancer, among others). This report focuses on key imaging technologies used in the process of performing biopsies (ultrasound, magnetic resonance imaging [MRI], computed tomography [CT] and others). The report also reviews the supply chain from manufacturers to surgeons.

The report excludes drugs used during a biopsy and any device that is used in the cancer treatment process.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.